Kimura Y, Koga H, Araki N, Mugita N, Fujita N, Takeshima H, Nishi T, Yamashima T, Saido T C, Yamasaki T, Moritake K, Saya H, Nakao M
Department of Tumor Genetics and Biology, Kumamoto University School of Medicine, Honjo, Japan.
Nat Med. 1998 Aug;4(8):915-22. doi: 10.1038/nm0898-915.
Neurofibromatosis type 2 (NF2) protein, also known as merlin or schwannomin, is a tumor suppressor, and NF2 is mutated in most schwannomas and meningiomas. Although these tumors are dependent on NF2, some lack detectable NF2 mutations, which indicates that alternative mechanisms exist for inactivating merlin. Here, we demonstrate cleavage of merlin by the ubiquitous protease calpain and considerable activation of the calpain system resulting in the loss of merlin expression in these tumors. Increased proteolysis of merlin by calpain in some schwannomas and meningiomas exemplifies tumorigenesis linked to the calpain-mediated proteolytic pathway.
2型神经纤维瘤病(NF2)蛋白,也称为默林蛋白或雪旺瘤蛋白,是一种肿瘤抑制因子,在大多数神经鞘瘤和脑膜瘤中NF2发生突变。尽管这些肿瘤依赖于NF2,但有些肿瘤却检测不到NF2突变,这表明存在使默林蛋白失活的其他机制。在此,我们证明了普遍存在的蛋白酶钙蛋白酶可切割默林蛋白,并且钙蛋白酶系统大量激活,导致这些肿瘤中默林蛋白表达缺失。在一些神经鞘瘤和脑膜瘤中,钙蛋白酶对默林蛋白的蛋白水解作用增强,这例证了与钙蛋白酶介导的蛋白水解途径相关的肿瘤发生过程。